SE0100903D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- SE0100903D0 SE0100903D0 SE0100903A SE0100903A SE0100903D0 SE 0100903 D0 SE0100903 D0 SE 0100903D0 SE 0100903 A SE0100903 A SE 0100903A SE 0100903 A SE0100903 A SE 0100903A SE 0100903 D0 SE0100903 D0 SE 0100903D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- inhibitors
- mmp12
- useful
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/10—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Priority Applications (64)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100903A SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
NZ528108A NZ528108A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
JP2002573759A JP2004527511A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
EEP200300450A EE200300450A (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
PL02364705A PL364705A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
KR10-2003-7011989A KR20030082990A (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
CZ20032501A CZ20032501A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metaloproteinasy |
CNA028099273A CN1509274A (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
PL02364714A PL364714A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CA002444526A CA2444526A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
EEP200300452A EE200300452A (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
EP02704034A EP1370536A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
MXPA03008180A MXPA03008180A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa. |
RU2003127731/04A RU2003127731A (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ |
PCT/SE2002/000479 WO2002074752A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
UA2003098169A UA74624C2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CA002440475A CA2440475A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CZ20032502A CZ20032502A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metalloproteinasy |
JP2002573758A JP2004523582A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
PCT/SE2002/000475 WO2002074750A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
KR1020037011980A KR100865836B1 (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
MXPA03008183A MXPA03008183A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa. |
HU0400193A HUP0400193A3 (en) | 2001-03-15 | 2002-03-13 | Imidazolindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them |
HU0400328A HUP0400328A3 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitor azoles and pharmaceutical compositions containing them |
US10/471,501 US20040116486A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
IL15765002A IL157650A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
SK1091-2003A SK10912003A3 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
BR0208062-1A BR0208062A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
CNB028097890A CN1313448C (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
HU0400206A HUP0400206A3 (en) | 2001-03-15 | 2002-03-13 | Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them |
EP02704038A EP1370538A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
BR0207985-2A BR0207985A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
MXPA03008187A MXPA03008187A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasas. |
IL15757002A IL157570A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
BR0208105-9A BR0208105A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
SK1094-2003A SK10942003A3 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
IL15765802A IL157658A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CA002440632A CA2440632A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
UA2003098167A UA77169C2 (en) | 2001-03-15 | 2002-03-13 | Hidantoine derivatives, pharmaceutical composition, their use |
AU2002237633A AU2002237633B2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
NZ528141A NZ528141A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
PL02365107A PL365107A1 (en) | 2001-03-15 | 2002-03-13 | Compounds |
CZ20032498A CZ20032498A3 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
RU2003127736/04A RU2293730C2 (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ, их применение и фармацевтические композиции на их основе |
EP02704033A EP1370535A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
RU2003127732/04A RU2003127732A (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ |
SK1093-2003A SK10932003A3 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
KR10-2003-7011983A KR20030082988A (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
MYPI20020912A MY129188A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
US10/471,499 US20040110809A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CNA028100417A CN1509275A (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
EEP200300439A EE200300439A (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
PCT/SE2002/000474 WO2002074749A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
JP2002573761A JP2004527512A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
US10/471,808 US20040147573A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
ARP020100945A AR035444A1 (es) | 2001-03-15 | 2002-03-15 | Compuestos inhibidores de metaloproteinasas, composicion farmaceutica, metodo de tratamiento, y uso de estos compuestos para la preparacion de medicamentos |
ZA200306733A ZA200306733B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
ZA200306738A ZA200306738B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
IS6944A IS6944A (is) | 2001-03-15 | 2003-09-10 | Málmpróteinasatálmar |
IS6945A IS6945A (is) | 2001-03-15 | 2003-09-10 | Málmpróteinasatálmar |
IS6948A IS6948A (is) | 2001-03-15 | 2003-09-11 | M βlmproteinasat βlmar |
NO20034025A NO20034025L (no) | 2001-03-15 | 2003-09-11 | Metalloproteinaseinhibitorer |
NO20034032A NO20034032L (no) | 2001-03-15 | 2003-09-11 | Metallproteinase-inhibitorer |
NO20034027A NO326088B1 (no) | 2001-03-15 | 2003-09-11 | Metalloproteinaseinhibitorer, farmasoytiske sammensetninger inneholdende slike samt anvendelser derav |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100903A SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100903D0 true SE0100903D0 (sv) | 2001-03-15 |
Family
ID=20283375
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100903A SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
Country Status (25)
Country | Link |
---|---|
US (2) | US20040116486A1 (sv) |
EP (2) | EP1370538A1 (sv) |
JP (2) | JP2004527512A (sv) |
KR (2) | KR100865836B1 (sv) |
CN (2) | CN1313448C (sv) |
AR (1) | AR035444A1 (sv) |
AU (1) | AU2002237633B2 (sv) |
BR (2) | BR0207985A (sv) |
CA (2) | CA2444526A1 (sv) |
CZ (2) | CZ20032498A3 (sv) |
EE (2) | EE200300450A (sv) |
HU (2) | HUP0400328A3 (sv) |
IL (2) | IL157658A0 (sv) |
IS (2) | IS6945A (sv) |
MX (2) | MXPA03008183A (sv) |
MY (1) | MY129188A (sv) |
NO (2) | NO20034032L (sv) |
NZ (2) | NZ528108A (sv) |
PL (2) | PL365107A1 (sv) |
RU (2) | RU2293730C2 (sv) |
SE (1) | SE0100903D0 (sv) |
SK (2) | SK10912003A3 (sv) |
UA (2) | UA74624C2 (sv) |
WO (2) | WO2002074752A1 (sv) |
ZA (2) | ZA200306738B (sv) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5300399A1 (es) | 2000-02-25 | 2003-07-31 | Astrazeneca Ab | Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen |
US7005439B2 (en) * | 2000-06-20 | 2006-02-28 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
CA2447475A1 (en) | 2001-05-25 | 2002-12-05 | Chu-Biao Xue | Hydantion derivatives as inhibitors of matrix metalloproteinases |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
MY131170A (en) * | 2002-03-28 | 2007-07-31 | Nissan Chemical Ind Ltd | Therapeutic agent for glomerular disease |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0202692D0 (sv) * | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
FR2845000B1 (fr) * | 2002-09-27 | 2005-05-27 | Oreal | Utilisation d'un compose heterocyclique ou de l'un de ses sels pour stimuler ou induire la pousse des cheveux et/ou freiner leur chute |
SE0401763D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
SE0401762D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
KR101197325B1 (ko) * | 2004-08-19 | 2012-11-05 | 큐피에스 엘엘씨 | 대식 세포 엘라스타아제의 억제제인 5-[3-(4-벤질옥시페닐티오)-퓨르-2-일]-이미다졸리딘-2,4-디온 및 유사 화합물 |
JPWO2006051937A1 (ja) * | 2004-11-15 | 2008-05-29 | 塩野義製薬株式会社 | ヘテロ5員環誘導体 |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
KR101441365B1 (ko) | 2006-05-08 | 2014-09-18 | 어리어드 파마슈티칼스, 인코포레이티드 | 모노시클릭 헤테로아릴 화합물 |
US8461167B2 (en) | 2006-05-08 | 2013-06-11 | Ariad Pharmaceuticals, Inc. | Acetylenic heteroaryl compounds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
ES2313841B1 (es) * | 2007-06-26 | 2010-01-12 | Proyecto De Biomedicina Cima, S.L. | Composiciones para tratamiento anti-fibrinolitico. |
AU2009314631B2 (en) | 2008-11-12 | 2014-07-31 | Takeda Pharmaceutical Company Limited | Pyrazinopyrazines and derivatives as kinase inhibitors |
US8492556B2 (en) * | 2011-11-10 | 2013-07-23 | Allergan, Inc. | 2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators |
EP2907512A1 (en) | 2014-02-14 | 2015-08-19 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Inhibitors of MMP-12 as antiviral Agents |
PE20191501A1 (es) | 2016-12-16 | 2019-10-22 | Pfizer | Agonistas receptores de glp-1 y sus usos de los mismos |
EP3793995B1 (en) | 2018-05-15 | 2024-01-10 | Foresee Pharmaceuticals USA, Inc. | Matrix metalloproteinase (mmp) inhibitors and methods of use thereof |
Family Cites Families (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2745875A (en) * | 1953-06-30 | 1956-05-15 | Hoechst Ag | Preparation of nu-acylamino-phenylpropane diols |
US3452040A (en) * | 1966-01-05 | 1969-06-24 | American Home Prod | 5,5-disubstituted hydantoins |
US3529019A (en) * | 1968-04-23 | 1970-09-15 | Colgate Palmolive Co | Alkylaryloxy alanines |
US3849574A (en) * | 1971-05-24 | 1974-11-19 | Colgate Palmolive Co | Alpha-substituted-beta-arylthioalkyl amino-acids,for increasing heart rate |
US4315031A (en) * | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
JPS61212292A (ja) * | 1985-03-19 | 1986-09-20 | Mitsui Toatsu Chem Inc | D−α−アミノ酸の製造方法 |
JPH0597814A (ja) * | 1991-10-02 | 1993-04-20 | Ajinomoto Co Inc | 5−(ヒドロキシメチル)ヒダントイン誘導体の製法 |
PH31245A (en) * | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
US5246943A (en) * | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
EP0640594A1 (en) * | 1993-08-23 | 1995-03-01 | Fujirebio Inc. | Hydantoin derivative as metalloprotease inhibitor |
US6166041A (en) * | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
WO1997019075A1 (en) * | 1995-11-22 | 1997-05-29 | Darwin Discovery Limited | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
GB9616643D0 (en) * | 1996-08-08 | 1996-09-25 | Chiroscience Ltd | Compounds |
US5919790A (en) * | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
ATE212619T1 (de) * | 1996-10-22 | 2002-02-15 | Upjohn Co | Alpha-amino sulfonyl hydroxamsäure als matrix metalloproteinase inhibitoren |
HUP0003362A3 (en) * | 1997-05-06 | 2001-04-28 | Novo Nordisk As | Piperidine derivatives and pharmaceutical compositions containing them |
DE59802394D1 (de) * | 1997-05-09 | 2002-01-24 | Hoechst Ag | Substituierte Diaminocarbonsäuren |
TR199903287T2 (xx) * | 1997-07-31 | 2000-09-21 | Abbott Laboratories | Matriks metaloproteinazlar�n�n ters hidroksamat inhibit�rleri. |
KR20010040698A (ko) * | 1998-02-04 | 2001-05-15 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 기질 분해 메탈로프로테이나제를 억제하는 술포닐아미노유도체 |
US6329418B1 (en) * | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
AU4074799A (en) * | 1998-05-14 | 1999-11-29 | Du Pont Pharmaceuticals Company | Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
JP2002518368A (ja) * | 1998-06-17 | 2002-06-25 | デュポン ファーマシューティカルズ カンパニー | メタロプロテイナーゼ阻害剤としての環式ヒドロキサム酸類 |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
DK1004578T3 (da) * | 1998-11-05 | 2004-06-28 | Pfizer Prod Inc | 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater |
EP1150975A1 (en) * | 1998-12-31 | 2001-11-07 | Aventis Pharmaceuticals Inc. | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 |
US6340691B1 (en) * | 1999-01-27 | 2002-01-22 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
US20020006920A1 (en) * | 1999-07-22 | 2002-01-17 | Robinson Ralph Pelton | Arylsulfonylamino hydroxamic acid derivatives |
DE60026404T2 (de) * | 1999-08-02 | 2006-10-19 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Benzothiophen-Derivaten |
EA005373B1 (ru) * | 1999-08-12 | 2005-02-24 | Фармация Италия С.П.А. | Производные 3(5)-аминопиразола, способ их получения и их применение в качестве противоопухолевых средств |
US6525202B2 (en) * | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
US20020065219A1 (en) * | 2000-08-15 | 2002-05-30 | Naidu B. Narasimhulu | Water soluble thiazolyl peptide derivatives |
US20020091107A1 (en) * | 2000-09-08 | 2002-07-11 | Madar David J. | Oxazolidinone antibacterial agents |
BR0208105A (pt) * | 2001-03-15 | 2004-03-09 | Astrazeneca Ab | Inibidores de metaloproteinase |
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
CA2447475A1 (en) * | 2001-05-25 | 2002-12-05 | Chu-Biao Xue | Hydantion derivatives as inhibitors of matrix metalloproteinases |
GB0114004D0 (en) * | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
TWI220073B (en) * | 2003-07-24 | 2004-08-01 | Au Optronics Corp | Method for manufacturing polysilicon film |
SE0401763D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
US7648992B2 (en) * | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-03-15 SE SE0100903A patent/SE0100903D0/sv unknown
-
2002
- 2002-03-13 BR BR0207985-2A patent/BR0207985A/pt not_active IP Right Cessation
- 2002-03-13 EP EP02704038A patent/EP1370538A1/en not_active Withdrawn
- 2002-03-13 RU RU2003127736/04A patent/RU2293730C2/ru not_active IP Right Cessation
- 2002-03-13 UA UA2003098169A patent/UA74624C2/uk unknown
- 2002-03-13 CA CA002444526A patent/CA2444526A1/en not_active Abandoned
- 2002-03-13 NZ NZ528108A patent/NZ528108A/en unknown
- 2002-03-13 US US10/471,501 patent/US20040116486A1/en not_active Abandoned
- 2002-03-13 WO PCT/SE2002/000479 patent/WO2002074752A1/en active IP Right Grant
- 2002-03-13 MX MXPA03008183A patent/MXPA03008183A/es unknown
- 2002-03-13 CA CA002440475A patent/CA2440475A1/en not_active Abandoned
- 2002-03-13 IL IL15765802A patent/IL157658A0/xx unknown
- 2002-03-13 SK SK1091-2003A patent/SK10912003A3/sk not_active Application Discontinuation
- 2002-03-13 JP JP2002573761A patent/JP2004527512A/ja active Pending
- 2002-03-13 US US10/471,499 patent/US20040110809A1/en not_active Abandoned
- 2002-03-13 UA UA2003098167A patent/UA77169C2/uk unknown
- 2002-03-13 CZ CZ20032498A patent/CZ20032498A3/cs unknown
- 2002-03-13 NZ NZ528141A patent/NZ528141A/en unknown
- 2002-03-13 MY MYPI20020912A patent/MY129188A/en unknown
- 2002-03-13 IL IL15765002A patent/IL157650A0/xx unknown
- 2002-03-13 EE EEP200300450A patent/EE200300450A/xx unknown
- 2002-03-13 EP EP02704033A patent/EP1370535A1/en not_active Withdrawn
- 2002-03-13 HU HU0400328A patent/HUP0400328A3/hu unknown
- 2002-03-13 CZ CZ20032501A patent/CZ20032501A3/cs unknown
- 2002-03-13 KR KR1020037011980A patent/KR100865836B1/ko not_active IP Right Cessation
- 2002-03-13 KR KR10-2003-7011983A patent/KR20030082988A/ko not_active Application Discontinuation
- 2002-03-13 CN CNB028097890A patent/CN1313448C/zh not_active Expired - Fee Related
- 2002-03-13 PL PL02365107A patent/PL365107A1/xx not_active Application Discontinuation
- 2002-03-13 PL PL02364705A patent/PL364705A1/xx not_active Application Discontinuation
- 2002-03-13 EE EEP200300452A patent/EE200300452A/xx unknown
- 2002-03-13 BR BR0208062-1A patent/BR0208062A/pt not_active IP Right Cessation
- 2002-03-13 RU RU2003127731/04A patent/RU2003127731A/ru not_active Application Discontinuation
- 2002-03-13 MX MXPA03008187A patent/MXPA03008187A/es not_active Application Discontinuation
- 2002-03-13 JP JP2002573758A patent/JP2004523582A/ja active Pending
- 2002-03-13 WO PCT/SE2002/000474 patent/WO2002074749A1/en active IP Right Grant
- 2002-03-13 CN CNA028099273A patent/CN1509274A/zh active Pending
- 2002-03-13 HU HU0400193A patent/HUP0400193A3/hu unknown
- 2002-03-13 AU AU2002237633A patent/AU2002237633B2/en not_active Ceased
- 2002-03-13 SK SK1094-2003A patent/SK10942003A3/sk not_active Application Discontinuation
- 2002-03-15 AR ARP020100945A patent/AR035444A1/es unknown
-
2003
- 2003-08-28 ZA ZA200306738A patent/ZA200306738B/en unknown
- 2003-08-28 ZA ZA200306733A patent/ZA200306733B/en unknown
- 2003-09-10 IS IS6945A patent/IS6945A/is unknown
- 2003-09-11 NO NO20034032A patent/NO20034032L/no unknown
- 2003-09-11 NO NO20034027A patent/NO326088B1/no not_active IP Right Cessation
- 2003-09-11 IS IS6948A patent/IS6948A/is unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0100903D0 (sv) | Compounds | |
SE0100902D0 (sv) | Compounds | |
ATE227264T1 (de) | Metalloproteinase-inhibitoren | |
NO20041493L (no) | Kjemiske forbindelser. | |
CY1106132T1 (el) | Παραγωγα πιπepιδινης ως αναστολεις καναλιου καλιου | |
DK1385515T3 (da) | Spiropyrazole forbindelser | |
WO2004083174A3 (en) | Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors | |
DE60335359D1 (de) | Phthalazinonderivate | |
SE0000540D0 (sv) | New compounds | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
SE0103710D0 (sv) | Compounds | |
UY28014A1 (es) | Compuestos quimicos | |
EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
ATE235462T1 (de) | Metalloproteinase-inhibitoren | |
NO20021409D0 (no) | Hastighets-kontrollerte partikler | |
PT1419163E (pt) | Imidazopiridinas triciclicas | |
MY128164A (en) | Compounds | |
SV2003000981A (es) | Fenil-heterociclil-eteres ref. pcs10973 | |
NO20015892D0 (no) | Inhibitorer av metallproteinaser | |
ATE526323T1 (de) | Die hiv-protease hemmende verbindungen | |
BRPI0416678A (pt) | pirazolpirimidinas | |
DK1562604T3 (da) | Prostaglandinforbindelser til behandling af fedme | |
ATE349427T1 (de) | Tryptaseinhibitoren | |
SE0403003D0 (sv) | Chemical compound 1 | |
ATE539074T1 (de) | Die hiv-protease hemmende verbindungen |